AbbVie Inc (ABBV)

Index:

S&P 100

$ 207.55
   
  • Change Today:
    $-3.05
  • 52 Week High: $216.66
  • 52 Week Low: $164.99
  • Currency: US Dollars
  • Shares Issued: 1,765.26m
  • Volume: 644
  • Market Cap: $366,379m
  • RiskGrade: 122
  • Beta: 0.45

Latest ShareCast News

AstraZeneca sells hypertension drug rights; Ends Allergan deal

By Frank Prenesti

Date: Monday 27 Jan 2020

(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.

AbbVie Inc Tips & Analysis

No recent information was found.

AbbVie Inc News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AbbVie Inc Market Data

Currency US Dollars
Share Price $ 207.55
Change Today $ -3.05
% Change -1.45 %
52 Week High $216.66
52 Week Low $164.99
Volume 644
Shares Issued 1,765.26m
Market Cap $366,379m
Beta 0.45
RiskGrade 122

What The Brokers Say

Strong Buy 7
Buy 13
Neutral 9
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-Aug-2025

Time Volume / Share Price
16:00 676,273 @ $207.55
16:00 2,714 @ $207.47
15:59 294 @ $207.47
15:59 100 @ $207.46
15:59 100 @ $207.47

Top of Page